CARYSIL Intrinsic Value
CARYSIL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹956.00 | ₹764.80 - ₹1147.20 | +18.9% | EPS: ₹38.24, Sector P/E: 25x |
| Book Value Method | asset | ₹2010.62 | ₹1809.56 - ₹2211.68 | +150.0% | Book Value/Share: ₹885.00, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹1608.50 | ₹1447.65 - ₹1769.35 | +100.0% | Revenue/Share: ₹1633.33, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹1608.50 | ₹1447.65 - ₹1769.35 | +100.0% | EBITDA: ₹204.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹1313.06 | ₹1050.45 - ₹1575.67 | +63.3% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹244.74 | ₹220.27 - ₹269.21 | -69.6% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹708.97 | ₹638.07 - ₹779.87 | -11.8% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹1608.50 | ₹1447.65 - ₹1769.35 | +100.0% | ROE: 20.3%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹872.61 | ₹785.35 - ₹959.87 | +8.5% | EPS: ₹38.24, BVPS: ₹885.00 |
Want to compare with current market value? Check CARYSIL share price latest .
Valuation Comparison Chart
CARYSIL Intrinsic Value Analysis
What is the intrinsic value of CARYSIL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of CARYSIL (CARYSIL) is ₹1313.06 (median value). With the current market price of ₹804.25, this represents a +63.3% variance from our estimated fair value.
The valuation range spans from ₹244.74 to ₹2010.62, indicating ₹244.74 - ₹2010.62.
Is CARYSIL undervalued or overvalued?
Based on our multi-method analysis, CARYSIL (CARYSIL) appears to be trading below calculated value by approximately 63.3%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.06 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.85 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 20.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.99x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for CARYSIL
Additional stock information and data for CARYSIL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹58 Cr | ₹7 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹71 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹52 Cr | ₹16 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹45 Cr | ₹28 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹30 Cr | ₹20 Cr | Positive Free Cash Flow | 8/10 |